Jie Zhang
Affiliations: | Georgia State University, Atlanta, GA, United States |
Google:
"Jie Zhang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Shan Y, Si R, Wang J, et al. (2020) Discovery of novel anti-angiogenesis agents. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization. European Journal of Medicinal Chemistry. 205: 112654 |
Pan X, Liang L, Sun Y, et al. (2019) Discovery of novel Bcr-Abl inhibitors with flexible linker. Part 1: Confirmation optimization of phenyl-1H-indazol-3-amine as hinge binding moiety. European Journal of Medicinal Chemistry. 178: 232-242 |
Wang J, Chen Q, Shan Y, et al. (2019) Activity-based proteomic profiling: The application of photoaffinity probes in the target identification of bioactive molecules Trends in Analytical Chemistry. 115: 110-120 |
Shan Y, Si R, Wang J, et al. (2018) Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs. European Journal of Medicinal Chemistry. 164: 440-447 |
Pan X, Liang L, Si R, et al. (2018) Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol. European Journal of Medicinal Chemistry. 163: 1-9 |
Zhan Y, Zhang H, Dai B, et al. (2018) A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer. Oncology Reports |
Shan Y, Wang B, Zhang J. (2018) New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs. Medicinal Research Reviews |
Zhang L, Shan Y, Ji X, et al. (2017) Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget. 8: 104745-104760 |
Li C, Shan Y, Sun Y, et al. (2017) Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4. European Journal of Medicinal Chemistry |
Sun Y, Shan Y, Li C, et al. (2017) Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors. European Journal of Medicinal Chemistry. 141: 373-385 |